Rockbridge Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-50
| Closed | -$20.3K | – | 617 |
|
|
2023
Q4 | $20.3K | Buy |
+50
| New | +$20.3K | ﹤0.01% | 325 |
|
|
2022
Q3 | – | Sell |
-50
| Closed | -$14.1K | – | 581 |
|
|
2022
Q2 | $14.1K | Hold |
50
| – | – | ﹤0.01% | 329 |
|
|
2022
Q1 | $13.3K | Hold |
50
| – | – | ﹤0.01% | 467 |
|
|
2021
Q4 | $11K | Hold |
50
| – | – | ﹤0.01% | 556 |
|
|
2021
Q3 | $9K | Hold |
50
| – | – | ﹤0.01% | 539 |
|
|
2021
Q2 | $10K | Hold |
50
| – | – | ﹤0.01% | 537 |
|
|
2021
Q1 | $11K | Buy |
50
+20
| +67% | +$4.4K | ﹤0.01% | 499 |
|
|
2020
Q4 | $7K | Hold |
30
| – | – | ﹤0.01% | 540 |
|
|
2020
Q3 | $8K | Hold |
30
| – | – | ﹤0.01% | 491 |
|
|
2020
Q2 | $9K | Buy |
+30
| New | +$9K | ﹤0.01% | 443 |
|